{"transactions":[{"id":703072,"issuer":{"id":6962,"kind":"organization","name":"Telomir Pharmaceuticals, Inc."},"owners":[{"id":28593,"kind":"person","name":"Whalen Matthew Pratt","position":1,"cik":"0002033867","reported_name":"Whalen Matthew Pratt","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Non-Qualified Stock Options (right to buy)","published_at":"2026-07-27T20:30:13.000Z","date":"2026-04-16","kind":"grant","planned":false,"acquired":true,"shares":50000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"The exercise price of the stock options issued to the Reporting Person is equal to the closing price of the Issuer's common stock on April 16, 2026."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The stock options were issued to the Reporting Person on April 16, 2026, pursuant to a grant under the Issuer's 2023 Omnibus Incentive Plan, as amended and restated (the \"Plan\"). All of the options vested immediately upon issuance."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"The stock options were issued to the Reporting Person on April 16, 2026, pursuant to a grant under the Issuer's 2023 Omnibus Incentive Plan, as amended and restated (the \"Plan\"). All of the options vested immediately upon issuance."}],"balance_after":50000,"derivative":{"exercise_price":1.34,"expiration_date":"2036-04-16","underlying":"Common Stock","underlying_shares":50000},"source":{"system":"sec-edgar","filing":"0001493152-26-034813","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/2033867/000149315226034813/ownership.xml","form_type":"4"}},{"id":738096,"issuer":{"id":7362,"kind":"organization","name":"MIRA PHARMACEUTICALS, INC."},"owners":[{"id":28593,"kind":"person","name":"Whalen Matthew Pratt","position":1,"cik":"0002033867","reported_name":"Whalen Matthew Pratt","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Options (right to buy)","published_at":"2026-06-15T21:00:06.000Z","date":"2026-06-12","kind":"grant","planned":false,"acquired":true,"shares":50000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"The exercise price of the stock options issued to the Reporting Person is equal to the closing price of the Issuer's common stock on June 12, 2026."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The stock options were issued to the Reporting Person on June 12, 2026 (the \"Grant Date\"), pursuant to the Issuer's 2022 Omnibus Incentive Plan, as amended and restated (the \"Plan\"). 50% of the options vest on the six-month anniversary of the grant date, and the remaining 50% vest on the one-year anniversary of the Grant Date."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"Represents 50,000 stock options that were issued to the Reporting Person on June 12, 2026, that vest in equal halves on the six and 12 month anniversaries of the grant date, pursuant to a grant under the Plan at an exercise price of $0.94 each."}],"balance_after":50000,"derivative":{"exercise_price":0.94,"expiration_date":"2036-06-12","underlying":"Common Stock","underlying_shares":50000},"source":{"system":"sec-edgar","filing":"0001493152-26-028715","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/2033867/000149315226028715/ownership.xml","form_type":"4"}},{"id":766375,"issuer":{"id":6962,"kind":"organization","name":"Telomir Pharmaceuticals, Inc."},"owners":[{"id":28593,"kind":"person","name":"Whalen Matthew Pratt","position":1,"cik":"0002033867","reported_name":"Whalen Matthew Pratt","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Incentive Stock Options (right to buy)","published_at":"2026-05-23T00:00:21.000Z","date":"2026-05-21","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":25000,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The reporting person agreed to cancellation of the option granted to him on 08/27/2024, in exchange for a new option having a lower exercise price."}],"balance_after":0,"derivative":{"exercise_price":5.02,"exercise_date":"2024-08-27","expiration_date":"2034-08-27","underlying":"Common Stock","underlying_shares":25000},"source":{"system":"sec-edgar","filing":"0001493152-26-025115","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/2033867/000149315226025115/ownership.xml","form_type":"4"}},{"id":766374,"issuer":{"id":6962,"kind":"organization","name":"Telomir Pharmaceuticals, Inc."},"owners":[{"id":28593,"kind":"person","name":"Whalen Matthew Pratt","position":1,"cik":"0002033867","reported_name":"Whalen Matthew Pratt","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Incentive Stock Options (right to buy)","published_at":"2026-05-23T00:00:21.000Z","date":"2026-05-21","kind":"grant","planned":false,"acquired":true,"shares":25000,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The reporting person agreed to cancellation of the option granted to him on 08/27/2024, in exchange for a new option having a lower exercise price."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The options are fully exercisable."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"The reporting person agreed to cancellation of the option granted to him on 08/27/2024, in exchange for a new option having a lower exercise price."}],"balance_after":25000,"derivative":{"exercise_price":1.3,"expiration_date":"2036-05-21","underlying":"Common Stock","underlying_shares":25000},"source":{"system":"sec-edgar","filing":"0001493152-26-025115","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/2033867/000149315226025115/ownership.xml","form_type":"4"}},{"id":1337498,"issuer":{"id":7362,"kind":"organization","name":"MIRA PHARMACEUTICALS, INC."},"owners":[{"id":28593,"kind":"person","name":"Whalen Matthew Pratt","position":1,"cik":"0002033867","reported_name":"Whalen Matthew Pratt","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Options (right to buy)","published_at":"2024-12-10T22:15:40.000Z","date":"2024-12-09","kind":"grant","planned":false,"acquired":true,"shares":25000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"The exercise price of the stock options issued to the Reporting Person is equal to the closing price of the Issuer's common stock on December 6, 2024."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The stock options were issued to the Reporting Person on December 6, 2024 (the \"Grant Date\"), pursuant to the Issuer's 2022 Omnibus Incentive Plan, as amended and restated. 50% of the options vest on the six-month anniversary of the grant date, and the remaining 50% vest on the one-year anniversary of the Grant Date."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"25,000 stock options were issued to the Reporting Person on the Grant Date, pursuant to the Issuer's 2022 Omnibus Incentive Plan, as amended and restated. 50% of the options vest on the six-month anniversary of the grant date, and the remaining 50% vest on the one-year anniversary of the Grant Date."}],"balance_after":25000,"derivative":{"exercise_price":1.19,"expiration_date":"2034-12-09","underlying":"Common Stock","underlying_shares":25000},"source":{"system":"sec-edgar","filing":"0001493152-24-049507","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/2033867/000149315224049507/ownership.xml","form_type":"4"}},{"id":1420107,"issuer":{"id":6962,"kind":"organization","name":"Telomir Pharmaceuticals, Inc."},"owners":[{"id":28593,"kind":"person","name":"Whalen Matthew Pratt","position":1,"cik":"0002033867","reported_name":"Whalen Matthew Pratt","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Incentive Stock Options (right to buy)","published_at":"2024-08-29T20:05:10.000Z","date":"2024-08-27","kind":"grant","planned":false,"acquired":true,"shares":25000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"The exercise price of the stock options issued to the Reporting Person is equal to the closing price of the Issuer's common stock on August 26, 2024."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The stock options were issued to the Reporting Person on August 26, 2024, pursuant to a grant under the Issuer's 2023 Omnibus Incentive Plan, as amended and restated (the \"Plan\"). Fifty percent of the stock options vested immediately upon issuance and the remaining fifty percent of the stock options are to vest on February 26, 2025."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"The stock options were issued to the Reporting Person on August 26, 2024, pursuant to a grant under the Issuer's 2023 Omnibus Incentive Plan, as amended and restated (the \"Plan\"). Fifty percent of the stock options vested immediately upon issuance and the remaining fifty percent of the stock options are to vest on February 26, 2025."}],"balance_after":25000,"derivative":{"exercise_price":5.02,"expiration_date":"2034-08-27","underlying":"Common Stock","underlying_shares":25000},"source":{"system":"sec-edgar","filing":"0001493152-24-034367","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/2033867/000149315224034367/ownership.xml","form_type":"4"}}]}